Daniel P Flaherty Selected Research

adenylyl cyclase 1

1/2022

Optimization of a Pyrimidinone Series for Selective Inhibition of Ca2+/Calmodulin-Stimulated Adenylyl Cyclase 1 Activity for the Treatment of Chronic Pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel P Flaherty Research Topics

Disease

4	Neoplasms (Cancer) 02/2021 - 12/2016
3	Infections 01/2021 - 10/2020
2	Pain (Aches) 01/2022 - 01/2019
2	Chronic Pain 01/2022 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2021 - 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2021
1	Sepsis (Septicemia) 01/2021
1	Genomic Instability 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2016

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2022 - 01/2019
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022 - 01/2019
2	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 02/2021 - 01/2020
1	adenylyl cyclase 1IBA 01/2022
1	PyrimidinonesIBA 01/2022
1	Biological ProductsIBA 02/2021
1	Deubiquitinating EnzymesIBA 02/2021
1	Linezolid (Zyvox)FDA Link 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	dorzolamide (Trusopt)FDA LinkGeneric 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	1,3,4-oxadiazoleIBA 01/2019
1	5' Untranslated Regions (5' UTR)IBA 01/2019
1	Nucleic AcidsIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2016
1	Glycoproteins (Glycoprotein)IBA 12/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2016
1	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 12/2016

Therapy/Procedure

1	Therapeutics 01/2021